Dr. Vince Gao, founder and serves as Chief Executive Officer, has more than 18 years' experience in leading life science R&D and business. Dr. Gao has a deep passion for using high-technology to improve people’s health and quality of life and increase the value of medical services. Most recently he served as the Executive President of Health Division of BGI, the world largest genomics company, where he pioneered the MS-Seq test for inborn errors of metabolism won the Top 10 Innovative Product Award at the 2013 China International Innovation Expo and his multi-omics preventive health approach served thousands of clients. Prior to joining BGI, Dr. Gao spent over 14 years at a global leading life science company AB Sciex for a variety of executive roles, including Laboratory Director for Japan and China, China General Manager and Asia Pacific Senior Business Director driving over USD $100 million annual business and overseeing more than 100 staff. Prior to joining AB Sciex, Dr. Gao served as the Senior Scientist of Drug Metabolism at AstraZeneca, a world-class pharmaceutical company, where he contributed significantly the development of an anti-breast cancer drug Arimidex of over USD $1 billion annual revenue. Prior to joining AstraZeneca, Dr. Gao served as Scientist at Hemagen, an US regenerative medicine company. Dr. Gao received his MS and PhD degrees in Bioanalytical Chemistry from The Northeastern University in the US.

Dr. Gao is Scientific Advisor of Biotechnology Research Institute at Hong Kong University of Science & Technology, Vice President of China International Talent Development Center Hong Kong Branch, Scientific Advisor of Beijing Union Hospital Clinical Laboratory, Senior Advisor of Shanghai Xuhui Hospital Clinical Laboratory, Visiting Professor of Hainan University, Scientific Advisor of Hainan Food and Drug Administration, Scientific Advisor and Honorary Director of Criminal Science Institute of Chongqing Public Security Bureau.

Dr. Guofeng Yang serves as Director of Business Development at Govita Tech Limited. Prior joining Govita, Dr. Yang worked for the ROBERT BOSCH Group for 13 years. He has led various product divisions and Merge and Acquisition projects of BOSCH in Asia. Dr. Yang specializes in high tech product development and operation. He is also specialist at company integration and restructuring matters and has long range extensive working experiences in manufacturing sector in China and Germany. Dr. Yang completed his Engineer PH.D in the Tongji University (Shanghai). Before that, he got his Master Degree of Mechanical Engineering from the Bochum University, Germany.

Mr. Duncan Yu, is the Chief Operating Officer of BGI and oversees BGI International Development Centre since 2014. Mr. Yu graduated from the University of Iowa in 1991 in Biochemistry. Prior to joining BGI, he has been working in GE Healthcare and Life Sciences, as General Manager for Greater China and Asia Pacific for the development of Genomics & Proteomics Systems.

Dr. Vince Gao, serves as Chief Executive Officer and Chief Scientific Officer, has more than 18 years' experience in leading life science R&D and business. Dr. Gao has a deep passion for using high-technology to improve people’s health and quality of life and increase the value of medical services. Most recently he served as the Executive President of Health Division of BGI, the world largest genomics company, where he pioneered the MS-Seq test for inborn errors of metabolism won the Top 10 Innovative Product Award at the 2013 China International Innovation Expo and his multi-omics preventive health approach served thousands of clients. Prior to joining BGI, Dr. Gao spent over 14 years at a global leading life science company AB Sciex for a variety of executive roles, including Laboratory Director for Japan and China, China General Manager and Asia Pacific Senior Business Director driving over USD $100 million annual business and overseeing more than 100 staff. Prior to joining AB Sciex, Dr. Gao served as the Senior Scientist of Drug Metabolism at AstraZeneca, a world-class pharmaceutical company, where he contributed significantly the development of an anti-breast cancer drug Arimidex of over USD $1 billion annual revenue. Prior to joining AstraZeneca, Dr. Gao served as Scientist at Hemagen, an US regenerative medicine company. Dr. Gao received his MS and PhD degrees in Bioanalytical Chemistry from The Northeastern University in the US.

Dr. Gao is Scientific Advisor of Biotechnology Research Institute at Hong Kong University of Science & Technology, Vice President of China International Talent Development Center Hong Kong Branch, Scientific Advisor of Beijing Union Hospital Clinical Laboratory, Senior Advisor of Shanghai Xuhui Hospital Clinical Laboratory, Visiting Professor of Hainan University, Scientific Advisor of Hainan Food and Drug Administration, Scientific Advisor and Honorary Director of Criminal Science Institute of Chongqing Public Security Bureau.

Dr. Eva Li is Senior Compliance and HR Manager who has been with Govita Laboratory from the beginning. She overviews the analytical method as well as routine laboratory operation and closely collaborates with clinicians in order to provide the best possible service. She has previously spent seven years in academia where she focused on application of LC-MS technology in, back then, newly emerging fields of metabolomics and lipidomics. Since the completion of her PhD in Bioanalytical Sciences at the University of Manchester, UK, she was passionate about bridging the gap between cutting-edge scientific research and applied clinical diagnostics. Most recently, she has worked in Prof. Christopher Buckley’s group (Institute of Inflammation and Aging, University of Birmingham, UK) on a research project exploring use of LC-MS/MS technology for novel diagnostic purposes in chronic inflammatory disorders.

Dr. Yang Liu, serves as Operation Director, has more than 10 years of experience in bioanalytical R&D and more than 3 years of experience in managing commercial laboratory. Dr. Liu has a great passion for using LCMSMS platform to develop novel methods in different applied market. Most recently she served as the Deputy Department Manager of SGS (SZ), the world leading 3rd-party testing company, where she oversaw central lab QA and daily operation to assure high quality report provided to clients on time. Prior to joining SGS, Dr. Liu studied and worked in UCLA Olympic Analytical Laboratory, focusing on developing alternative and novel method to detect testosterone doping. Dr. Liu received her PhD degree in Peking Union Medical College, Beijing.

Dr. Wings Loo is our Senior Medical Laboratory Technologist. He has more than 15 years of experience in the field of genetic, epigenetic and biological markers. He completed his PhD projects in endocrine biomarkers in Tohoku University School of Medicine, Japan. Dr Loo has obtained another PhD at the Faculty of Dentistry, The University of Hong Kong investigating genetic aberrations in oral disease subjects. He has completed his post-doctoral fellow’s project in the West China College of Stomatology, Sichuan University studying the correlation of genes of cytokines, inflammatory mediators and alveolar bone resorption in control and periodontitis patients. Recently, Dr. Loo has applied Tai Chi Chuan as a tool to relieve stress and aging in cancer survivors and healthy subjects, their biomarkers were compared. He is currently participating research projects in West China College of Stomatology, Sichuan University and Xiangya Hospital, Central South University. These include application of stem cells for anti-aging, and the correlation of genetic factors and bone resorption.

Dr. WU received her PhD degree in City University of Hong Kong. So far, she already has 15 years’ experience of LCMS analysis. Her research interests include the cutting-edge LCMS technologies and their application in drug, environmental, and biomedical analysis. She devotes herself to the LCMSMS based clinical metabolism analysis since she joined Govita Laboratory. She is delighted to see the improvement of people’s health and life quality due to our efforts.

Mr. Hans Huang has worked his way to become a Bioinformatics Manager since he joined Govita in September 2016. He received his bachelor’s degree in chemical technology from the Hong Kong Polytechnic University and master’s degree in nutrition science from the Chinese University of Hong Kong. With his background in life science and skills in programming, he focuses on applying advanced biological knowledge on govita's genetic and metabolic tests.

Dr. Ravinder J. Singh, Ph.D., is the director of the Mayo Clinic Endocrine Laboratory. Dr. Singh studies the application of liquid chromatography-tandem mass spectrometry (LC-MS/MS) to clinical laboratory analysis. Many of the methods that Dr. Singh developed are now considered as reference methods. They have subsequently been utilized for method standardization efforts as well as to establish clinical disease correlation, which he has published numerous papers with his collaborators.

Dr. Singh’s work has directly contributed to improving methods for the clinical diagnosis of Cushing’s disease, pheochromocytoma and congenital adrenal hyperplasia. At present, he is working to discover innovative ways to better understand the uses of LC-MS/MS in providing patients with faster and more accurate diagnoses.

Dr. Moshe Szyf has led the promotion of the esoteric science of epigenetics to a wider community, he is the founder of behavioral epigenetics and promoted it in more than 390 public and key-note scientific lectures to a wide spectrum of audiences globally. He was the first to discover the translational value of DNA methylation in his TIPS paper from 1994. He founded the first Pharma in the world to explore epigenetic drugs Methylgene Inc in Montreal, he is the cofounder of the Sackler program in epigenetics, and the chief editor of the first scientific journal in Epigenetics “Epigenetics” (IF >5) and led multinational collaborative research projects.

Dr. Szyf has more than 260 PubMed listed papers on the biological role of DNA methylation that span a broad spectrum from basic mechanisms to translation to cancer diagnostics and therapeutics as well as behavior, neurosciences, chronic pain and addiction. Productivity has been increasing in recent years with more than 95 papers listed in the last five years and 22 in 2015. Dr. Szyf is an inventor of a spectrum of patents covering the broadest applications of DNA methylation.

Dr. Richard F. Walker, Ph.D, R.Ph received a BS in pharmacy, and doctorate in a physiology at Rutgers University. Prior his doctrate, he received his masters in biochemistry at New Mexico State University. He completed an internship in neuroanatomy/electrophysiology at Emory University College of Medicine, and postdoctoral fellowships in neuroendocrinology at Duke University College of Medicine (Center for the Study of Aging and Human Development) and in neuropharmacology at the University of California, Berkeley. Dr. Walker held tenured faculty positions at Clemson University (Department of Zoology) and at the University of Kentucky, College of Medicine (Department of Anatomy and Molecular Biology/Sanders-Brown Research Center on Aging).

He left academia for a brief hiatus in the pharmaceutical industry serving as Director of Toxicology at SmithKline Beecham Pharmaceutical Corp. At the same time he was also a research professor in the Department of Pharmacology at the Medical College of Pennsylvania and later at the University of South Florida (USF) College of Medicine. In addition to his research duties at USF, Dr. Walker served as Director for Research Compliance and also Director of USF CARES (Clinical Alliance for Research, Education and Service). He has been the recipient of many federal (NSF, NIH, DOD), state and local research grants and has published extensively in his field of interest which is primarily directed towards understanding the cause of senescence and treating functional deficits associated with organismal aging.

Dr. Walker is currently Editor-in-Chief of Clinical Interventions in Aging, a source of evidence-based information for practitioners of age-management medicine published by Dove Medical Press, Auckland and London. He has also written a book “Why We Age: Insight into the cause of growing old”. He is partner in ProSoma LLC which manufactures and distributes anti-aging products, and heads a private consulting company offering regulatory and scientific services to physicians and other health-care professionals.

Dr. Donald H. Chace, PhD, MSFS, FACB is the Chief Scientific Officer for Medolac Laboratories, a public benefit corporation. He is one of the primary developers of newborn metabolic screening using tandem Mass Spectrometry. Dr. Chace is an expert in metabolism and clinical chemistry using mass spectrometry and dried blood spot analysis. Millions of newborns are screened annually for inherited genetic disease using his patented methods.

He has published nearly 100 peer reviewed articles and has presented a at numerous conferences which include areas in Neonatology, Clinical Chemistry, Newborn Screening, Mass Spectrometry and Forensic Science. He is well known for his simple analogies in his presentations or his classroom experiment using jelly beans or M&Ms to explain how compounds are measured in blood. He is currently working on validating the benefits of human breast milk in the improvement in growth of premature infants. In addition, he is developing both analytical and bioinformatic tools to aid the neonatologist is delivering more personalized care from a nutritional perspective to the premature infant.

Sourav Kundu earned a Doctor of Engineering (Dr. Engg. / Ph.D.) from Tokyo Metropolitan University in March of 1996 in the area of Artificial Intelligence application to Non-Linear Control Systems. Sourav has strong and extensive work experience in Control System Design, Artificial Intelligence (AI) , Blockchain, Distributed Ledger Technology (DLT), BFSI Technology, specially in the Insurance domain and has been engaged in a variety of multi-geography Bio-IT, Finance Technology and AI, Accounting Automation, Regional Finance Allocation projects in Technology Leadership Roles with top-level Fortune 100 companies. Sourav also held consulting roles as Lead Histotechnology consultant for Biomedical Process flow design in histopathology laboratories, implementing LIMS and Clinical Trials' related bar-coding, Logistics for sample collection, Gross Room automation and Robotics based Automation using Blockchain, at BioInformatics laboratories at the Hong Kong Science park, including Govitatech Laboratories. Sourav's insurance consulting roles were with multinational insurers like AXA Life Insurance, Cigna International etc., Technology consulting roles with with Sun Microsystems, Citi Group Japan, UBS Japan and Cigna Global Individual (Cigna Corp.) Hong Kong. Sourav, has also taught courses in Business, IT PMO, E-Commerce, Computer Science, Mechanical Engineering, etc. at universities in Japan, USA, Turkey, Australia, Italy, France, The Netherlands, Germany, UK, Singapore and India in addition to various companies in Japan, USA and Hong Kong, Sourav has current overall responsibility for the AI, Blockchain, IoT and Information Technology Platform, Strategy Leadership and overall IT Solution Architecture / Delivery at Knowledge Solutions Group, a global consulting company based in Japan. He is also Honorary Visiting Professor of Industrial Information Technology at Sangyo Gijutsu Daigaku (AIIT, Shinagawa, Japan). Sourav shares his time between learning new technologies, teaching, traveling and spending time with his 12 years old daughter in Hong Kong.

Dr. Lauren Bramley is the founder and managing director of her namesake Hong Kong-based multidisciplinary medical and dental practice. She established a second clinic in Whistler Lauren Bramley & Partners Health & Innovation, specializing in anti-aging medicine and procedures.

Dr. Bramley takes an innovative approach to health, integrating a combination of cutting-edge preventative testing methods, medical genomics, lifestyle recommendations, nutrition and medicine to ensure that her clients live longer, healthier and happier lives. She successfully combines western medicine and the latest anti-aging innovations with the eastern philosophies of body harmony and the power of natural healing for an all-encompassing approach to well-being. Her broad international experience has facilitated a high level of sensitivity regarding the diverse cultural and social differences of her clients. In addition to her core general practice, Dr. Bramley has a special interest in physical fitness and endocrinology, and she is particularly recognized as an innovative global leader in the ever-evolving field of anti-aging medicine. Dr. Bramley is the co-author of the best-selling children’s nutrition book ‘The Baby’s Table’ (Random House Canada, 2004). She has also appeared in numerous high-profile newspapers and magazines, and on various television shows talking about preventative health topics and anti-aging issues. In 2016, she was a featured speaker at TEDx Vail, with the focus of her presentation being making informed decisions by monitoring four key bio-markers for optimal health, well-being and appearance. Dr. Bramley is a certified medical doctor in the USA, Canada, Australia and Hong Kong.

Dr. Kao completed a five-year general surgery program at the University of Washington and received his board certification by the American Board of Surgery in 1997. He quickly developed an interest in surgical endoscopy (minimally invasive surgery through the use of a small camera scope). Dr. Kao became a clinical professor at the University’s Center for Video Endoscopic Surgery and taught residents and fellow surgeons this technique. He then completed a three-year plastic surgery program at the University of Southern California. Dr. Kao continues to expand his interest in endoscopic surgery to facial plastic surgery. He has taught other surgeons these specialized techniques at the endoscopic plastic surgery educational seminar in Los Angeles, California.

Dr. Kao has authored numerous publications that have appeared in professional journals. He has also lectured at national and regional meetings with presentations to such groups as The California Society of Plastic Surgeons. He appeared on the discovery learning channel featuring his endoscopic facial work. Dr. Kao is a Staff Plastic Surgeon at Saint John’s Health Center in Santa Monica. He is a member of California Society of Plastic Surgeons and is certified by the American Board of Surgery and the American Board of Plastic Surgery. He now is the Founder and the Plastic Surgeon of the KAO center in the US.

Mr. Daniel Pentek is an MBA educated professional with a deep technical background and 15+ years' experience in the instrumentation and medical device industry. His expertise lies in identifying and developing new technology for competitive advantage. Mr. Pentek holds a track record of accomplishments in product development, marketing and management in a variety of technology spaces, having delivered within ISO 9001 and 13485 environments. He has demonstrated strengths in MS/MS, LC/GC Chromatography expert, innovation champion, product positioning, fiscal planning and budgets, as well as his achievements in his Master’s in Chemistry and MBA.